Size matters: the biochemical logic of ligand type in endocrine crosstalk

Abstract

The endocrine system is a fundamental type of long-range cell–cell communication that is important for maintaining metabolism, physiology, and other aspects of organismal homeostasis. Endocrine signaling is mediated by diverse blood-borne ligands, also called hormones, including metabolites, lipids, steroids, peptides, and proteins. The size and structure of these hormones are fine-tuned to make them bioactive, responsive, and adaptable to meet the demands of changing environments. Why has nature selected such diverse ligand types to mediate communication in the endocrine system? What is the chemical, signaling, or physiologic logic of these ligands? What fundamental principles from our knowledge of endocrine communication can be applied as we continue as a field to uncover additional new circulating molecules that are claimed to mediate long-range cell and tissue crosstalk? This review provides a framework based on the biochemical logic behind this crosstalk with respect to their chemistry, temporal regulation in physiology, specificity, signaling actions, and evolutionary development.

Keywords

endocrine / ligand size / metabolites / signaling / evolution

References

[1] Banting FG, Best CH, Collip JB et al. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 1922; 12: 141- 6.

[2] Vecchio I, Tornali C, Bragazzi NL et al. The discovery of insulin: an important milestone in the history of medicine. Front Endocrinol 2018; 9: 613.

[3] Allen BM. Experiments in the transplantation of the hypophysis of adult Rana pipiens to tadpoles. Science 1920; 52: 274- 6.

[4] Citterio CE, Targovnik HM, Arvan P. The role of thyroglobulin in thyroid hormonogenesis. Nat Rev Endocrinol 2019; 15: 323- 38.

[5] Kendall EC. Isolation of the iodine compound which occurs in the thyroid: first paper. J Biol Chem 1919; 39: 125- 47.

[6] Kuo T, McQueen A, Chen TC et al. Regulation of glucose homeostasis by glucocorticoids. Adv Exp Med Biol 2015; 872: 99- 126.

[7] Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 2013; 34: 309- 38.

[8] Adams AC, Yang C, Coskun T et al. The breadth of FGF21’s metabolic actions are governed by FGFR1 in adipose tissue. Mol Metab 2013; 2: 31- 7.

[9] Nishimura T, Nakatake Y, Konishi M et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 2000; 1492: 203- 6.

[10] Friedman J. The long road to leptin. J Clin Invest 2016; 126: 4727- 34.

[11] Emmerson PJ, Wang F, Du Y et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med 2017; 23: 1215- 9.

[12] Hsu JY, Crawley S, Chen M et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 2017; 550: 255- 9.

[13] Macia L, Tsai VW, Nguyen AD et al. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One 2012; 7: e34868.

[14] Patel S, Alvarez-Guaita A, Melvin A et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab 2019; 29: 707- 18.e8.

[15] Bernard C. On the production of sugar in the liver of man and animals. The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science 1851; 2: 326- 30.

[16] Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010; 141: 1117- 34.

[17] Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell 2017; 169: 381- 405.

[18] Chang L, Chiang SH, Saltiel AR. Insulin signaling and the regulation of glucose transport. Mol Med 2004; 10: 65- 71.

[19] Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 2016; 126: 12- 22.

[20] Brown KJ, Formolo CA, Seol H et al. Advances in the proteomic investigation of the cell secretome. Expert Rev Proteomics 2012; 9: 337- 45.

[21] Shen X, Kellogg R, Panyard DJ et al. Multi-omics microsampling for the profiling of lifestyle-associated changes in health. Nat Biomed Eng 2023.

[22] Deshmukh AS, Peijs L, Beaudry JL et al. Proteomics-based comparative mapping of the secretomes of human brown and white adipocytes reveals EPDR1 as a novel batokine. Cell Metab 2019; 30: 963- 75.e7.

[23] Jiang Z, Zhao M, Voilquin L et al. Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis. Cell Metab 2021; 33: 1836- 52.e11.

[24] Chen L, Lu W, Wang L et al. Metabolite discovery through global annotation of untargeted metabolomics data. Nat Methods 2021; 18: 1377- 85.

[25] Taguchi T, Kodera Y, Oba K et al. Suprabasin-derived bioactive peptides identified by plasma peptidomics. Sci Rep 2021; 11: 1047.

[26] Wojtowicz WM, Vielmetter J, Fernandes RA et al. A human IgSF cell-surface interactome reveals a complex network of protein-protein interactions. Cell 2020; 182: 1027- 43.e17.

[27] Yang NJ, Hinner MJ. Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods Mol Biol 2015; 1266: 29- 53.

[28] Douglass J, Civelli O, Herbert E. Polyprotein gene expression: generation of diversity of neuroendocrine peptides. Annu Rev Biochem 1984; 53: 665- 715.

[29] Eick GN, Colucci JK, Harms MJ et al. Evolution of minimal specificity and promiscuity in steroid hormone receptors. PLoS Genet 2012; 8: e1003072.

[30] Foltz IN, Hu S, King C et al. Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex. Sci Transl Med 2012; 4: 162ra153.

[31] Agrawal A, Parlee S, Perez-Tilve D et al. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity. Mol Metab 2018; 13: 45- 55.

[32] Lan T, Morgan DA, Rahmouni K et al. FGF19, FGF21 and an FGFR1/β-Klotho-activating antibody act on the nervous system to regulate body weight and glycemia. Cell Metab 2017; 26: 709- 18.e3.

[33] Caron A, Lee S, Elmquist JK et al. Leptin and brain-adipose crosstalks. Nat Rev Neurosci 2018; 19: 153- 65.

[34] Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659- 60.

[35] Yore MM, Syed I, Moraes-Vieira PM et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 2014; 159: 318- 32.

[36] Zhou P, Santoro A, Peroni OD et al. PAHSAs enhance hepatic and systemic insulin sensitivity through direct and indirect mechanisms. J Clin Invest 2019; 129: 4138- 50.

[37] Rapport MM, Green AA, Page IH. Crystalline serotonin. Science 1948; 108: 329- 30.

[38] Twarog BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol-Legacy Content 1953; 175: 157- 61.

[39] Physical Biology of the Cell. Routledge & CRC Press. Accessed date Nov 1, 2023.

[40] Rusakov DA, Savtchenko LP, Zheng K et al. Shaping the synaptic signal: molecular mobility inside and outside the cleft. Trends Neurosci 2011; 34: 359- 69.

[41] Gutierrez JM, Feizi A, Li S et al. Genome-scale reconstructions of the mammalian secretory pathway predict metabolic costs and limitations of protein secretion. Nat Commun 2020; 11: 68.

[42] Dale HH, Dudley HW. The presence of histamine and acetylcholine in the spleen of the ox and the horse. J Physiol 1929; 68: 97- 123.

[43] Fatt P, Katz B. Spontaneous subthreshold activity at motor nerve endings. J Physiol 1952; 117: 109- 28.

[44] Axelrod J, Hertting G, Potter L. Effect of drugs on the uptake and release of ³H-Norepinephrine in the rat heart. Nature 1962; 194: 297.

[45] Euler USv. A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and nor-adrenaline. Acta Physiol Scand 1946; 12: 73- 97.

[46] Wasserman K. The anaerobic threshold measurement to evaluate exercise performance. Am Rev Respir Dis 1984; 129: S35- 40.

[47] Needham DM. Machina Carnis. The Biochemistry of Muscular Contraction in Its Historical Development. Cambridge University Press, UK. 1971.

[48] Reddy A, Bozi LHM, Yaghi OK et al. pH-gated succinate secretion regulates muscle remodeling in response to exercise. Cell 2020; 183: 62- 75.e17.

[49] Cahill GF. Starvation in man. N Engl J Med 1970; 282: 668- 75.

[50] Li VL, He Y, Contrepois K et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature 2022; 606: 785- 90.

[51] Johann K, Cremer AL, Fischer AW et al. Thyroid-hormone-induced browning of white adipose tissue does not contribute to thermogenesis and glucose consumption. Cell Rep 2019; 27: 3385- 400.e3.

[52] Agudelo LZ, Femenía T, Orhan F et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 2014; 159: 33- 45.

[53] Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 2012; 15: 606- 14.

[54] Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14: 263- 83.

[55] Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012; 120: e60- 72.

[56] Serhan CN, Yang R, Martinod K et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009; 206: 15- 23.

[57] Ferreira SH, Moncada S, Vane JR. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol 1997; 120: 401- 12.

[58] Kawaguchi H, Pilbeam CC, Harrison JR et al. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Relat Res 1995; 36: 46.

[59] Fan W, Tang S, Fan X et al. SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B. eLife 2021; 10: e67452.

[60] Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139- 50.

[61] Devaux PF. Lipid transmembrane asymmetry and flip-flop in biological membranes and in lipid bilayers. Curr Opin Struct Biol 1993; 3: 489- 94.

[62] Sun LP, Seemann J, Goldstein JL et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc Natl Acad Sci USA 2007; 104: 6519- 26.

[63] Griggs RC, Kingston W, Jozefowicz RF et al. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol (1985) 1989; 66: 498- 503.

[64] Geary N, Asarian L, Korach KS et al. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-α null mice. Endocrinology 2001; 142: 4751- 7.

[65] Morgan SA, Sherlock M, Gathercole LL et al. 11β-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes 2009; 58: 2506- 15.

[66] Dupre J, Ross SA, Watson D et al. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 1973; 37: 826- 8.

[67] Pi-Sunyer X, Astrup A, Fujioka K et al. A randomized, controlled trial of 30 mg of Liraglutide in weight management. N Engl J Med 2015; 373: 11- 22.

[68] Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656- 60.

[69] Clark JT, Kalra PS, Crowley WR et al. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984; 115: 427- 9.

[70] Ivy AC, Oldberg E. A hormone mechanism for gall-bladder contraction and evacuation. Am J Physiol-Legacy Content 1928; 86: 599- 613.

[71] Rehfeld JF. Cholecystokinin—From local gut hormone to ubiquitous messenger. Front Endocrinol (Lausanne) 2017; 8: 47.

[72] Brindley BA, Sokol RJ. Induction and augmentation of labor: basis and methods for current practice. Obstet Gynecol Surv 1988; 43: 730- 43.

[73] Matsunaga M, Kikusui T, Mogi K et al. Breastfeeding dynamically changes endogenous oxytocin levels and emotion recognition in mothers. Biol Lett 2020; 16: 20200139.

[74] Feldberg W, Gaddum JH. The chemical transmitter at synapses in a sympathetic ganglion. J Physiol 1934; 81: 305- 19.

[75] Tam JK, Lee LT, Jin J et al. Molecular evolution of GPCRs: secretin/secretin receptors. J Mol Endocrinol 2014; 52: T1- 14.

[76] Clark A, Lewis CE, Willis AC et al. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet 1987; 330: 231- 4.

[77] Westermark P, Wernstedt C, Wilander E et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986; 140: 827- 31.

[78] Batterham RL, Heffron H, Kapoor S et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 2006; 4: 223- 33.

[79] Gerich JE, Lorenzi M, Schneider V et al. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus Pathophysiologic and therapeutic implications. N Engl J Med 1974; 291: 544- 7.

[80] Kimball CP, Murlin JR. Aqueous extracts of pancreas: Ⅲ. some precipitation reactions of insulin. J Biol Chem 1923; 58: 337- 46.

[81] Goeddel DV, Kleid DG, Bolivar F et al. Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci USA 1979; 76: 106- 10.

[82] Markan KR, Naber MC, Ameka MK et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 2014; 63: 4057- 63.

[83] Nishimura T, Utsunomiya Y, Hoshikawa M et al. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1999; 1444: 148- 51.

[84] Potthoff MJ, Boney-Montoya J, Choi M et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. Cell Metab 2011; 13: 729- 38.

[85] Wang GX, Zhao XY, Meng ZX et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuating hepatic lipogenesis. Nat Med 2014; 20: 1436- 43.

[86] Scherer PE, Williams S, Fogliano M et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746- 9.

[87] Long JZ, Svensson KJ, Bateman LA et al. The secreted enzyme PM20D1 regulates lipidated amino acid uncouplers of mitochondria. Cell 2016; 166: 424- 35.

[88] Xu J, Li X, Chen W et al. Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling. J Exp Med 2023; 220: e20221123.

[89] Tso P, Balint JA. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 1986; 250: G715- 26.

[90] Welty FK, Lichtenstein AH, Barrett PHR et al. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol 1999; 19: 2966- 74.

[91] Murakami M, Naraba H, Tanioka T et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000; 275: 32783- 92.

[92] Henkel J, Frede K, Schanze N et al. Stimulation of fat accumulation in hepatocytes by PGE2-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis. Lab Investig 2012; 92: 1597- 606.

[93] Brakch N, Rist B, Beck-Sickinger AG et al. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. Biochemistry 1997; 36: 16309- 20.

[94] Lo CM, Nordskog BK, Nauli AM et al. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation? Am J Physiol Gastrointest Liver Physiol 2008; 294: G344- 52.

[95] Lo CC, Coschigano KT. ApoB48 as an efficient regulator of intestinal lipid transport. Front Physiol 2020; 11: 796.

[96] Brooks GA. Cell-cell and intracellular lactate shuttles. J Physiol 2009; 587: 5591- 600.

[97] Di Jeso B, Arvan P. Thyroglobulin from molecular and cellular biology to clinical endocrinology. Endocr Rev 2016; 37: 2- 36.

[98] Qiu S, Cai Y, Yao H et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Sig Transduct Target Ther 2023; 8: 132.

[99] Liu S, Gui Y, Wang MS et al. Serum integrative omics reveals the landscape of human diabetic kidney disease. Mol Metab 2021; 54: 101367.

[100] Scarale MG, Mastroianno M, Prehn C et al. Circulating metabolites associate with and improve the prediction of all-cause mortality in type 2 diabetes. Diabetes 2022; 71: 1363- 70.

[101] Lu P, Takai K, Weaver VM et al. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 2011; 3: a005058.

[102] Scholpp S, Brand M. Endocytosis controls spreading and effective signaling range of Fgf8 protein. Curr Biol 2004; 14: 1834- 41.

[103] Eguchi N, Hayashi H, Urade Y et al. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats. J Pharmacol Exp Ther 1988; 247: 671- 9.

[104] Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 2020; 16: 642- 53.

[105] Burnett LC, Skowronski AA, Rausch R et al. Determination of the half-life of circulating leptin in the mouse. Int J Obes (Lond) 2017; 41: 355- 9.

[106] Chen K, Arnold FH. Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide. Proc Natl Acad Sci USA 1993; 90: 5618- 22.

[107] Ahorukomeye P, Disotuar MM, Gajewiak J et al. Fish-hunting cone snail venoms are a rich source of minimized ligands of the vertebrate insulin receptor. Elife 2019; 8: e41574.

[108] Schranner D, Kastenmüller G, Schönfelder M et al. Metabolite concentration changes in humans after a bout of exercise: a systematic review of exercise metabolomics studies. Sports Med Open 2020; 6: 11.

[109] Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 2018; 19: 654- 72.

[110] Teruya T, Chaleckis R, Takada J et al. Diverse metabolic reactions activated during 58-hr fasting are revealed by non-targeted metabolomic analysis of human blood. Sci Rep 2019; 9: 854.

[111] Crown A, Clifton DK, Steiner RA. Neuropeptide signaling in the integration of metabolism and reproduction. Neuroendocrinology 2007; 86: 175- 82.

[112] Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013; 17: 819- 37.

[113] Boucher J, Kleinridders A, Ronald Kahn C. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor Perspect Biol 2014; 6: a009191.

[114] Zhao M, Jung Y, Jiang Z et al. Regulation of energy metabolism by receptor tyrosine kinase ligands. Front Physiol 2020; 11: 354.

[115] Zhang H, Liu J, Li CR et al. Deletion of Drosophila insulin-like peptides causes growth defects and metabolic abnormalities. Proc Natl Acad Sci USA 2009; 106: 19617- 22.

[116] Safavi-Hemami H, Lu A, Li Q et al. Venom insulins of cone snails diversify rapidly and track prey taxa. Mol Biol Evol 2016; 33: 2924- 34.

[117] Mukherjee S, Mondal S, Deshmukh AA et al. What gives an insulin hexamer its unique shape and stability? Role of ten confined water molecules. J Phys Chem B 2018; 122: 1631- 7.

[118] Elleri D, Dunger DB, Hovorka R. Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Med 2011; 9: 120.

[119] Menting JG, Yang Y, Chan SJ et al. Protective hinge in insulin opens to enable its receptor engagement. Proc Natl Acad Sci USA 2014; 111: E3395- 404.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.